Evidence map›Paper›PMID 27843912›Full record

ArticleFrontiers in medicine2016

Are Intensive Cares Worthwhile for Breast Cancer Patients: The Experience of an Oncological ICU.

Virginie Destrebecq, Ameye Lieveke, Thierry Berghmans, Marianne Paesmans, Jean-Paul Sculier, Anne-Pascale Meert

Abstract read
In one paragraph

Article in Frontiers in medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Virginie DestrebecqService des soins intensifs et urgences oncologiques & oncologie thoracique, Institut Jules Bordet, Université Libre de Bruxelles (ULB) , Brussels , Belgium.
Ameye LievekeData Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB) , Brussels , Belgium.
Thierry BerghmansService des soins intensifs et urgences oncologiques & oncologie thoracique, Institut Jules Bordet, Université Libre de Bruxelles (ULB) , Brussels , Belgium.
Marianne PaesmansData Centre, Institut Jules Bordet, Université Libre de Bruxelles (ULB) , Brussels , Belgium.
Jean-Paul SculierService des soins intensifs et urgences oncologiques & oncologie thoracique, Institut Jules Bordet, Université Libre de Bruxelles (ULB) , Brussels , Belgium.
Anne-Pascale MeertService des soins intensifs et urgences oncologiques & oncologie thoracique, Institut Jules Bordet, Université Libre de Bruxelles (ULB) , Brussels , Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOne among seven women will present with breast cancer for which major therapeutic advances led to a significant increase in survival and cure rates. During or after cancer treatment, severe complications may occur requiring admission in intensive care unit (ICU). Intensivists could be reluctant for accepting cancer patients in the ICU, and there are very few data about causes of admission and prognosis of patients with breast cancer admitted in the ICU for an acute complication. Our study seeks to determine, in a population of patients with breast cancer, the main causes for ICU admission and the predictors of death during hospital stay and prognostic factors for survival after hospital discharge.

methodsThis retrospective study includes all unplanned ICU admissions of patients with breast cancer in a cancer hospital from January 1, 2009 to December 31, 2014. To search for predictive factors of death during hospitalization, Mann-Whitney or Fisher Exact (or chi-square) tests were used for continuous variables or categorical variables, respectively. A logistic regression model was applied for multivariate analysis. Multivariate analysis of prognostic factors for survival after hospital discharge was performed with a Cox's proportional hazards model.

resultsOf 1586 ICU admissions during the study period, 282 (18%) concerned breast cancer of which 175 met the inclusion criteria. The main causes of admission were of cardiovascular (26%), respiratory (19%), neurologic (19%), or infectious (14%) origin. ICU death rate was 15% and, overall, 28% of the patients died during hospitalization. The median survival time after hospitalization was 12.8 months (95% CI: 8.2-20.7). Independent predictors of death during hospitalization were the sequential organ failure assessment (SOFA) score (OR 1.36, 95% CI 1.15-1.60), high GPT values (OR 3.70, 95% CI: 1.52-9.03), and cardiovascular disease (OR 0.23, 95% CI: 0.06-0.86). Independent predictors of death after hospital discharge were metastatic disease (HR 7.90, 95% CI 3.69-16.92), high GOT value (HR 3.22 95% CI: 1.93-5.36), simplified acute physiology score (SAPS) (HR 1.95 95% CI: 1.21-3.16), and therapeutic limitations during the first 24 h after ICU admission (HR 8.52 95% CI: 3.66-19.87).

conclusionIndependent predictors of death during hospitalization were related to the acute complications (SOFA score, GPT level and cardiovascular-related admission) while cancer parameters retained their prognostic significance for survival after hospital discharge (metastatic disease, therapeutic limitations).

Indexed as

breast cancerintensive caresurvival

Identifiers

PMID27843912
PMCPMC5086595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.